Cidara Therapeutics, Inc. Annual Return On Assets in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cidara Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2015 to 2023.
  • Cidara Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -127 %, a 746% decline year-over-year.
  • Cidara Therapeutics, Inc. annual Return On Assets for 2023 was -32.6 %, a 49.4% increase from 2022.
  • Cidara Therapeutics, Inc. annual Return On Assets for 2022 was -64.4 %, a 7.36% increase from 2021.
  • Cidara Therapeutics, Inc. annual Return On Assets for 2021 was -69.5 %, a 32.2% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -32.6 +31.8 +49.4% Jan 1, 2023 Dec 31, 2023
2022 -64.4 +5.11 +7.36% Jan 1, 2022 Dec 31, 2022
2021 -69.5 +33 +32.2% Jan 1, 2021 Dec 31, 2021
2020 -102 -40.8 -66.2% Jan 1, 2020 Dec 31, 2020
2019 -61.6 +5.98 +8.85% Jan 1, 2019 Dec 31, 2019
2018 -67.6 +1.97 +2.83% Jan 1, 2018 Dec 31, 2018
2017 -69.6 -18.7 -36.7% Jan 1, 2017 Dec 31, 2017
2016 -50.9 -19.6 -62.8% Jan 1, 2016 Dec 31, 2016
2015 -31.3 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.